Pfizer Inc
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PFE.DU | ANIP | APUS | AZN | PZS.F | 033270.KS | |
|---|---|---|---|---|---|---|
| Market cap | — | 1.72B | 4.17M | 297.51B | 71.30M | 254.57B |
| P/E (TTM) | — | 16.3 | — | 27.1 | 10.4 | — |
| Forward P/E | — | 7.4 | — | 17.0 | 18.0 | — |
| Price/book | — | 2.7 | 4.3 | 5.8 | 0.9 | — |
| Dividend yield | — | — | — | 1.69% | 1.91% | 3.85% |
| 1-year change | +27.77% | −20.59% | −88.39% | +12.81% | +16.52% | −17.48% |
| Today | +0.62% | +4.80% | −5.25% | +1.49% | +0.75% | +1.20% |
The closest companies by business. Prices may be delayed up to 20 min.
Latest news
All PFE.DU news ›Pfizer: 3 Key Takeaways for Long-Term Investors
The patent-expiry question is still open: whether cutting costs now buys enough time for late-stage trials to replace fading blockbuster revenue. New treatments and recent acquisitions are generating immediate sales growth that buffers…
Pfizer eyes Europe first for Lyme vaccine as prevalence rises in US
Pfizer’s Valneva-partnered Lyme disease vaccine is nearing a regulatory submission, with interest in preventative options against the tick-borne disease rising around the world. But the FDA won’t be its first stop. Rather, Europe will…
United Therapeutics buys out Pfizer royalties linked to lung disease therapy
United Therapeutics (UTHR) stock rises as the company eliminates Pfizer (PFE) royalties linked to lung disease drug ralinepag for $525M. Read more here. United Therapeutics (UTHR) traded higher in premarket trading on Wednesday after the…
Pfizer raises 2026 outlook to $62B-$64B revenue and $2.95-$3.05 adjusted EPS, targeting high single-digit revenue CAGR from 2028-2033
Pfizer Q3 2026 earnings highlight raised guidance, strong revenue growth, and pipeline updates amid 2027 pricing and LOE risks. Earnings Call Insights: Pfizer (PFE) Q3 2026 - "I'm pleased with another strong quarter for Pfizer." (Chairman…
Pfizer reports lower profits but lifts forecast
Pfizer reported lower profits Tuesday but raised its full-year forecast as it pointed to boosted sales from pharma assets added from acquisitions in recent years. The drugmaker, which has closed major deals with smaller companies…
Pfizer makes interim CFO permanent from November
Nordic Product Manager - urologi & reumatologi Clinical Trial Program Lead Faglig rådgiver til ATMP Danmark Head of Clinical Operations Territory Manager Point of Care (øst) Nordic Head of Commercial Excellence Senior Scientist / Principal…
Pfizer's Eliquis Price Gains Cover COVID Drop: Rapid Earnings Reaction
Pfizer's revenue didn't grow, but the mix underneath it changed a lot. Pfizer (PFE -1.14%) reported flat third-quarter revenue of $16.6 billion and raised its full-year outlook. Shares slipped about 0.2% in premarket trading. Eliquis and…
Pfizer Beats Expectations in Q3 and Raises Its Guidance. Is the Stock Due for a Big Rally?
The healthcare stock may finally have the catalyst that it needs to take off before the end of the year. On Tuesday, healthcare giant Pfizer (PFE -0.99%) reported its third-quarter results, which came in far better than expected.…
Moderna Climbs 5% Ahead of Earnings, Pfizer Eases Despite Raised Outlook, Merck Slides 2% Amid New Phase 3 Trial
Moderna surges on pre-earnings momentum, Pfizer dips after beating estimates and raising guidance, and Merck drops despite launching a new trial. When stock prices and headlines point in opposite directions across the sector, something…
International Business: Pfizer net profit up
Tue, 03 Nov 2026 Mon, 02 Nov 2026 Sun, 01 Nov 2026 Pfizer raised its full-year profit and revenue forecasts yesterday as strong demand for its recently acquired cancer drug Padcev and blockbuster blood thinner Eliquis led to…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- 247wallst.com24
- fool.com23
- seekingalpha.com15
- theglobeandmail.com15
- marketscreener.com14
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.